Diabetic Macular Edema News and Research

RSS
Fluid can leak into the center of the macula, the part of the eye where sharp, straight-ahead vision occurs. The fluid makes the macula swell, blurring vision. This condition is called macular edema. It can occur at any stage of diabetic retinopathy, although it is more likely to occur as the disease progresses. About half of the people with proliferative retinopathy also have macular edema.
Ranibizumab improves driving prospects for AMD patients

Ranibizumab improves driving prospects for AMD patients

Ranibizumab injections keep those with AMD driving longer

Ranibizumab injections keep those with AMD driving longer

pSivida reports revenues of $699,000 for fourth quarter 2012

pSivida reports revenues of $699,000 for fourth quarter 2012

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

Aerpio Therapeutics commences AKB-9778 Phase 1b/2a trial in diabetic macular edema

Factors predictive of successful DME treatment revealed

Factors predictive of successful DME treatment revealed

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Ethypharm, Ampio enter definitive agreement to manufacture Zertane

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Genentech receives FDA approval for Lucentis to treat diabetic macular edema

Lucentis receives FDA approval for treatment of diabetic macular edema

Lucentis receives FDA approval for treatment of diabetic macular edema

Regeneron reports total revenues of $304 million for second quarter 2012

Regeneron reports total revenues of $304 million for second quarter 2012

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

FDA clears pSivida's IND for injectable sustained-release micro-insert to treat posterior uveitis

Ampio announces advancement of NCE001 to preclinical development

Ampio announces advancement of NCE001 to preclinical development

Enrollment complete in Lux Biosciences Luveniq Phase 3 study for non-infectious uveitis

Enrollment complete in Lux Biosciences Luveniq Phase 3 study for non-infectious uveitis

Ampio announces results from Optina trial on DME

Ampio announces results from Optina trial on DME

Thiazolidinedione drugs linked with increased risk of DME in patients with Type 2 diabetes

Thiazolidinedione drugs linked with increased risk of DME in patients with Type 2 diabetes

Ampio’s CRO completes Optina clinical trial for DME

Ampio’s CRO completes Optina clinical trial for DME

Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan

Bayer Yakuhin, Santen enter co-promotion agreement for EYLEA Injection in Japan

IRIDEX launches non-invasive MicroPulse Laser Trabeculoplasty for glaucoma

IRIDEX launches non-invasive MicroPulse Laser Trabeculoplasty for glaucoma

JDRF, iCo Therapeutics partner for iCo-007 Phase II trial in DME

JDRF, iCo Therapeutics partner for iCo-007 Phase II trial in DME

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Positive data from Aerpio's AKB-9778 Phase 1 trial on DME

Ampio completes partial planned interim review in Optina trial for diabetic macular edema

Ampio completes partial planned interim review in Optina trial for diabetic macular edema